FDA Will Not Issue CBD RegulationsJanuary 31, 2023
The Food and Drug Administration announced it will not create a framework for CBD products. The decision comes after a lengthy review period which was expected to end in the formalization of rules governing the non-intoxicating substance’s inclusion in food and drink. Instead, the agency has concluded that its regulatory tools are not up to the task of overseeing CBD and will look to Congress for a path forward.
“The FDA’s existing foods and dietary supplement authorities provide only limited tools for managing many of the risks associated with CBD products,” wrote Janet Woodcock, principal deputy commissioner of the FDA. “A new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks. The agency is prepared to work with Congress on this matter.”—Danny SullivanSubscribe to Shanken News Daily’s Email Newsletter, delivered to your inbox each morning. You will also receive the Cannabis edition as part of your subscription.
GET YOUR FIRST LOOK AT 2021 DATA AND 2022 PROJECTIONS FOR THE WINE AND SPIRITS INDUSTRIES. ORDER YOUR 2022 IMPACT DATABANK REPORTS. CLICK HERE.